Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma - PubMed (original) (raw)
Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma
Ya-Wei Qiang et al. Bone. 2008 Apr.
Abstract
Expression of the Wnt signaling inhibitor, DKK1 by multiple myeloma cells is correlated with lytic bone disease in multiple myeloma. However, the mechanism(s) by which DKK1 contributes to this process is not clear. Herein, we analyzed the functional role of canonical Wnt signaling and Dkk1 inhibition of this pathway in bone morphogenic protein (BMP)-2-induced osteoblast differentiation. Osteoblast differentiation was measured by alkaline phosphatase (ALP) activity in murine (C2C12) and human pre-osteoblast (hFOB1.19) and osteoblast-like (Saos-2 and MG63) cell lines. Cytoplasmic beta-catenin protein was separated by E-cadherin-GST pull-down assay and analyzed by Western blotting. A dominant negative form of beta-catenin, Dkk1 and TCF reporter constructs were transfected into C2C12 cells. C2C12 cells were also transfected with siRNA specific to LRP5/6 to knockdown receptor expression. Canonical Wnt signaling was activated in these cell lines in response to Wnt3a as assessed by increased cytoplasmic, non-phosphorylated beta-catenin and TCF/LEF transcription activity. Recombinant Dkk1 and plasma from MM patients containing high levels of Dkk1 blocked Wnt3a-induced beta-catenin accumulation. Importantly, Dkk1 abrogated BMP-2 mediated osteoblast differentiation. The requirement for Wnt signaling in osteoblast differentiation was confirmed by the following observations: 1) overexpression of Dkk1 decreased endogenous beta-catenin and ALP activity; 2) silencing of Wnt receptor mRNAs blocked ALP activity; and 3) a dominant negative form of beta-catenin eliminated BMP-2-induced ALP activity. Furthermore, Wnt3a did not increase ALP activity nor did BMP-2 treatment result in beta-catenin stabilization indicating that cooperation between these two pathways is required, but they are not co-regulated by either ligand. These studies have revealed that autocrine Wnt signaling in osteoblasts is necessary to promote BMP-2-mediated differentiation of pre-osteoblast cells, while Wnt signaling alone is not capable of inducing such differentiation. Dkk1 inhibits this process and may be a key factor regulating pre-osteoblast differentiation and myeloma bone disease.
Similar articles
- Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E, Takahashi-Yanaga F, Miwa Y, Hirata M, Watanabe Y, Sato N, Morimoto S, Hirofuji T, Maeda K, Sasaguri T. Matsuzaki E, et al. J Bone Miner Res. 2006 Aug;21(8):1307-16. doi: 10.1359/jbmr.060512. J Bone Miner Res. 2006. PMID: 16869729 - Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.
Guo J, Cooper LF. Guo J, et al. Bone. 2007 Jan;40(1):57-67. doi: 10.1016/j.bone.2006.07.016. Epub 2006 Sep 7. Bone. 2007. PMID: 16956801 - BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S. Rawadi G, et al. J Bone Miner Res. 2003 Oct;18(10):1842-53. doi: 10.1359/jbmr.2003.18.10.1842. J Bone Miner Res. 2003. PMID: 14584895 - TGF-β-related mechanisms of bone destruction in multiple myeloma.
Matsumoto T, Abe M. Matsumoto T, et al. Bone. 2011 Jan;48(1):129-34. doi: 10.1016/j.bone.2010.05.036. Epub 2010 Jun 1. Bone. 2011. PMID: 20570621 Review. - [Regulation of microRNA in osteoblast differentiation and its clinical significance].
Zhou M, Li M, Yu X. Zhou M, et al. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Jun;26(6):755-9. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012. PMID: 22792778 Review. Chinese.
Cited by
- Deciphering the Role of LncRNAs in Osteoarthritis: Inflammatory Pathways Unveiled.
Hu K, Wen H, Song T, Che Z, Song Y, Song M. Hu K, et al. J Inflamm Res. 2024 Sep 20;17:6563-6581. doi: 10.2147/JIR.S489682. eCollection 2024. J Inflamm Res. 2024. PMID: 39318993 Free PMC article. Review. - A comparative analysis of transcriptomics of newly diagnosed multiple myeloma: exploring drug repurposing.
Giannakoulas A, Nikolaidis M, Amoutzias GD, Giannakoulas N. Giannakoulas A, et al. Front Oncol. 2024 Apr 16;14:1390105. doi: 10.3389/fonc.2024.1390105. eCollection 2024. Front Oncol. 2024. PMID: 38690165 Free PMC article. - Elucidation of molecular basis of osteolytic bone lesions in advanced multiple myeloma.
Shin D, Kim MJ, Chun S, Kim D, Lee C, Ahn KS, Jung E, Kim D, Lee BC, Hwang D, Kim Y, Yoon SS. Shin D, et al. Haematologica. 2024 Jul 1;109(7):2207-2218. doi: 10.3324/haematol.2023.283784. Haematologica. 2024. PMID: 38205555 Free PMC article. - Progress of Wnt Signaling Pathway in Osteoporosis.
Gao Y, Chen N, Fu Z, Zhang Q. Gao Y, et al. Biomolecules. 2023 Mar 6;13(3):483. doi: 10.3390/biom13030483. Biomolecules. 2023. PMID: 36979418 Free PMC article. Review. - Hyperthyroidism and Wnt Signaling Pathway: Influence on Bone Remodeling.
Mudri D, Bilić Ćurčić I, Meštrović L, Mihaljević I, Kizivat T. Mudri D, et al. Metabolites. 2023 Feb 6;13(2):241. doi: 10.3390/metabo13020241. Metabolites. 2023. PMID: 36837860 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials